Amgen | 8-K: Amgen reported fourth quarter and full year 2022 financial results, entered into the Share Purchase Agreement and received documentary materials of acquisition of Horizon
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.